Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Gynecol Oncol. 2016 Oct 11;143(3):596–603. doi: 10.1016/j.ygyno.2016.10.012

Table 3. Instrument results at baseline and follow-up timepoints.

Survey instrument Follow-up timepoint (months) No. of patients Median Score (range) P-value
FSFI
 Arousal 0 30 5.0 (0.0-6.0) ---
1 6 0.0 (0.0-3.9) 0.0002
6 18 4.8 (1.2-6.0) 0.999
12 13 5.1 (0.0-6.0) 0.900
24 12 3.8 (0.0-6.0) 0.897
36 5 3.6 (0.0-6.0) 1.000
48 4 5.9 (0.0-6.0) 0.975
60 3 4.5 (2.1-5.1) 0.989
 Desire 0 30 3.6 (1.2-6.0) ---
1 6 2.1 (1.2-3.6) 0.178
6 18 3.9 (1.8-6.0) 0.902
12 13 4.2 (2.4-5.4) 0.307
24 12 2.4 (1.2-6.0) 1.000
36 5 2.4 (1.8-6.0) 1.000
48 4 4.2 (3.0-4.8) 0.998
60 3 2.4 (2.4-4.2) 0.924
 Lubrication 0 30 5.7 (0.0-6.0) ---
1 6 0.0 (0.0-4.2) <0.0001
6 18 5.3 (2.1-6.0) 0.568
12 13 5.4 (0.0-6.0) 0.998
24 12 5.1(0.0-6.0) 1.000
36 5 3.0 (0.0-4.2) 0.549
48 4 5.0 (0.0-6.0) 1.000
60 3 4.2 (2.7-5.1) 1.000
 Orgasm 0 30 5.6 (0.0-6.0) ---
1 6 0.0 (0.0-4.4) 0.006
6 18 4.8 (1.2-6.0) 0.868
12 13 5.6 (0.0-6.0) 0.861
24 12 4.2 (0.0-5.6) 0.992
36 5 2.8 (0.0-6.0) 0.999
48 4 5.0 (0.0-5.6) 0.999
60 3 4.0 (3.2-5.6) 0.876
 Pain 0 30 4.4 (0.0-6.0) ---
1 5 0.0 (0.0-0.0) 0.010
6 18 4.8 (0.0-6.0) 0.894
12 13 4.8 (0.0-6.0) 0.999
24 12 4.8 (0.0-6.0) 0.987
36 5 4.0 (0.0-6.0) 1.000
48 4 5.0 (0.0-6.0) 1.000
60 3 4.8 (4.8-5.6) 0.754
 Satisfaction 0 30 5.2 (0.8-6.0) ---
1 6 2.8 (0.0-4.0) 0.026
6 18 4.4 (1.2-6.0) 0.965
12 13 5.6 (0.8-6.0) 0.823
24 12 3.4 (0.8-6.0) 0.895
36 5 4.4 (0.8-6.0) 0.875
48 4 5.4 (0.8-6.0) 0.732
60 3 4.4 (1.6-6.0) 0.920
 FSFI Total 0 30 27.5 (3.2-36.0) ---
1 5 5.8 (3.2-19.7) 0.004
6 18 27.2 (10.9-35.4) 0.855
12 13 31.1 (3.2-35.0) 0.837
24 12 21.6 (2.0-34.4) 0.969
36 5 20.8 (3.2-32.7) 1.000
48 4 31.0 (3.8-33.2) 1.000
60 3 26.1 (17.6-29.0) 0.985
FACT-Cx
 Functional well being 0 30 21.5 (4.0-28.0) ---
1 25 17.0 (5.0-28.0) 0.019
6 18 27.0 (11.0-28.0) 0.582
12 13 27.0 (20.0-28.0) 0.428
24 12 26.5 (16.0-28.0) 0.295
36 5 24.0 (20.0-27.0) 0.949
48 4 24.5 (23.0-28.0) 0.846
60 3 25.0 (24.0-28.0) 0.762
 Physical status 0 30 26.0 (19.0-28.0) ---
1 25 19.0 (1.0-28.0) <0.0001
6 18 26.9 (17.0-28.0) 0.995
12 13 26.0 (23.0-28.0) 1.000
24 12 27.0 (18.0-28.0) 1.000
36 5 24.5 (20.0-27.0) 0.750
48 4 21.5 (20.0-28.0) 0.573
60 3 28.0 (25.0-28.0) 1.000
 Emotional well being 0 30 16.5 (6.0-23.0) ---
1 25 20.0 (13.0-24.0) 0.004
6 18 20.5 (3.0-24.0) 0.007
12 13 22.0 (17.0-24.0) 0.001
24 12 21.0 (13.0-24.0) 0.002
36 5 18.0 (17.0-23.0) 0.349
48 4 22.5 (18.0-24.0) 0.032
60 3 21.0 (20.0-21.0) 0.194
 Social/family well being 0 30 22.0 (10.0-24.0) ---
1 25 21.0 (8.0-24.0) 0.999
6 18 21.5 (12.0-24.0) 1.000
12 13 21.0 (15.0-24.0) 0.967
24 12 21.0 (16.0-24.0) 0.997
36 5 20.0 (12.0-24.0) 0.845
48 4 20.0 (12.0-22.0) 0.572
60 3 23.0 (15.0-24.0) 1.000
 FACT-Cx Total 0 30 87.0 (46.0-100.0) ---
1 25 74.0 (41.0-101.0) 0.089
6 18 92.0 (51.0-104.0) 0.875
12 13 93.0 (75.0-104.0) 0.641
24 12 95.0 (63.0-103.0) 0.463
36 5 82.0 (78.0-101.0) 1.000
48 4 86.5 (77.0-102.0) 1.000
60 3 96.0 (85.0-101.0) 0.954
MDASI
 Symptom severity Total 0 30 15.0 (0.0-74.0) ---
1 26 22.0 (0.0-94.0) 0.800
6 18 7.5 (0.0-57.0) 0.869
12 13 6.0 (0.0-26.0) 0.350
24 12 4.0 (0.0-33.0) 0.412
36 5 17.0 (3.0-48.0) 1.000
48 4 15.5 (0.0-22.0) 0.998
60 3 14.0 (8.0-32.0) 1.000
 Symptom distress Total 0 30 4.5 (0.0-45.0) ---
1 26 9.0 (0.0-60.0) 0.043
6 18 0.0 (0.0-40.0) 0.945
12 13 0.0 (0.0-6.0) 0.523
24 12 0.0 (0.0-22.0) 0.795
36 5 0.0 (0.0-10.0) 0.975
48 4 0.0 (0.0-3.0) 0.924
60 3 6.0 (0.0-6.0) 1.000
SF12
 Bodily pain 0 29 5.0 (2.0-5.0) ---
1 26 3.0 (1.0-5.0) <0.0001
6 18 5.0 (3.0-5.0) 1.000
12 12 5.0 (3.0-5.0) 1.000
24 12 5.0 (3.0-5.0) 1.000
36 4 5.0 (4.0-5.0) 1.000
48 4 5.0 (5.0-5.0) 0.940
60 3 5.0 (4.0-5.0) 1.000
 General health 0 30 4.4 (1.0-5.0) ---
1 26 4.4 (2.0-5.0) 0.336
6 18 4.4 (2.0-5.0) 1.000
12 11 3.4 (2.0-5.0) 0.779
24 12 4.4 (3.4-5.0) 1.000
36 4 4.2 (2.0-5.0) 0.984
48 4 3.9 (3.4-4.4) 1.000
60 3 4.4 (3.4-5.0) 1.000
 Mental health 0 30 5.5 (3.0-7.0) ---
1 26 5.0 (3.0-7.0) 0.739
6 18 5.5 (3.0-6.0) 1.000
12 13 5.0 (3.0-8.0) 1.000
24 12 5.0 (3.0-6.0) 1.000
36 4 6.0 (5.0-8.0) 0.446
48 4 5.5 (4.0-8.0) 0.779
60 3 6.0 (5.0-6.0) 0.979
 Physical functioning 0 30 6.0 (2.0-6.0) ---
1 26 3.0 (2.0-6.0) <0.0001
6 18 6.0 (4.0-6.0) 1.000
12 13 6.0 (3.0-6.0) 0.981
24 12 6.0 (3.0-6.0) 1.000
36 4 5.5 (5.0-6.0) 0.966
48 4 6.0 (5.0-6.0) 1.000
60 3 6.0 (6.0-6.0) 1.000
 Role emotional 0 30 8.5 (2.0-10.0) ---
1 26 8.0 (2.0-10.0) 0.030
6 18 9.0 (4.0-10.0) 0.978
12 13 9.0 (8.0-10.0) 0.999
24 12 10.0 (9.0-10.0) 0.734
36 4 9.0 (6.0-10.0) 0.983
48 4 10.0 (6.0-10.0) 1.000
60 3 9.0 (8.0-10.0) 1.000
 Role physical 0 30 10.0 (4.0-10.0) ---
1 26 4.0 (2.0-10.0) <0.0001
6 18 10.0 (6.0-10.0) 0.985
12 13 9.0 (8.0-10.0) 1.000
24 12 10.0 (8.0-10.0) 1.000
36 4 9.0 (8.0-10.0) 0.991
48 4 10.0 (8.0-10.0) 1.000
60 3 10.0 (9.0-10.0) 1.000
 Social functioning 0 30 4.0 (2.0-5.0) ---
1 26 4.0 (1.0-5.0) 0.002
6 17 5.0 (4.0-5.0) 0.933
12 12 5.0 (4.0-5.0) 0.963
24 12 5.0 (4.0-5.0) 0.584
36 4 4.5 (4.0-5.0) 1.000
48 4 4.5 (2.0-5.0) 0.936
60 3 4.0 (4.0-5.0) 1.000
 Vitality 0 30 2.0 (1.0-5.0) ---
1 26 2.0 (1.0-5.0) 0.467
6 18 4.0 (1.0-5.0) 0.656
12 13 4.0 (1.0-4.0) 0.940
24 12 4.0 (2.0-5.0) 0.564
36 4 3.0 (2.0-4.0) 1.000
48 4 3.0 (2.0-4.0) 1.000
60 3 4.0 (4.0-4.0) 0.573
SWD
0 28 29.0 (6.0-30.0) ---
1 24 29.0 (12.0-30.0) 0.915
6 17 30.0 (21.6-30.0) 0.999
12 10 29.5 (22.0-30.0) 1.000
24 12 26.5 (6.0-30.0) 0.909
36 5 30.0 (10.8-30.0) 0.994
48 4 29.0 (24.0-30.0) 0.971
60 3 24.0 (6.0-30.0) 0.185

FSFI=Female Sexual Functioning Index, FACT-Cx=Functional Assessment of Cancer Therapy-Cervix, MDASI=MD Anderson Symptom Inventory, SF-12=General Health-Related Quality of Life, SWD=Satisfaction with Decision scale